product launch
Gartmore has launched its first healthcare hedge fund with a long/short equity strategy. The AlphaGen Arneb Fund was first incubated in-house in December 2001 and has achieved a net return of 18% since its inception. As a result of this success, it was decided the product would be launched to investors. It is to be managed by San Diego-based Paul Cluskey. According to Martin Phipps, head of hedge funds at Gartmore: "A non-directional investment style is used for the portfolio, similar to other equity long/short strategies in the AlphaGen range. Stock picking is purely bottom-up a...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes